GAB2 and chronic myelogenous leukemia, BCR-ABL1 positive: This suggests that the expression levels and signalling competence of Gab2 needs to be tightly controlled in Bcr-Abl+ CML in order to drive proliferation and to repress differentiation at the same time, raising the possibility that modulation of Gab2 signalling might represent a strategy to control this disease.